Skip to main content
Clinical Trials/NCT04558749
NCT04558749
Completed
Not Applicable

Assessment of Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic

Assiut University1 site in 1 country238 target enrollmentOctober 1, 2020
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Assiut University
Enrollment
238
Locations
1
Primary Endpoint
The mean scores anxiety and depression among pregnant women during COVID-19 pandemic
Status
Completed
Last Updated
last year

Overview

Brief Summary

Pregnancy and early parenthood are life changing periods characterized by intense emotions and a high vulnerability to emotional problems. Overall 10 - 20 % of pregnant women and women in early postpartum period suffer from mental health problems.

In the first months of 2020 , pregnant and breastfeeding women have also needed to face the COVID19 pandemic including the exceptional quarantine measures that have disturbed private and professional life . In addition to the fear of infection , these measures might have negatively impacted the emotional wellbeing of women . As depressive symptoms and anxiety in the pre and peripartum period have been associated with adverse maternal , neonatal and infant outcomes , the psychological impact of COVID19 , and its associated quarantine measures , on pregnant women and new mothers is cause for concern

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
February 28, 2022
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Mohamed Abbas

Principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • All pregnant women presented to the Antenatal care clinic, will be included in the study irrespective of the gestational age of the pregnancy

Exclusion Criteria

  • Women previously diagnosed with any psychiatric disorder.

Outcomes

Primary Outcomes

The mean scores anxiety and depression among pregnant women during COVID-19 pandemic

Time Frame: one hour

This scale is composed of two parts, part one measures anxiety traits and part two measures anxiety state. Each part comprises 20 statements. This scale is a (4) point scale, with a score ranging a minimum of 20 grades to a maximum of 80 grades.

Study Sites (1)

Loading locations...

Similar Trials